NCT06229158 Assessment of the Quality and Sexual Health Needs of Patients with Advanced-stage Cancer
| NCT ID | NCT06229158 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hospices Civils de Lyon |
| Condition | Advanced Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 120 participants |
| Start Date | 2024-02-05 |
| Primary Completion | 2025-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 120 participants in total. It began in 2024-02-05 with a primary completion date of 2025-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Sexual health is an important determinant of the overall health of a population, as addressed in the French National Strategy 2017-2030. For a long time neglected in oncology, sexual health is now part of clinical assessments in cancer support care and is fully integrated into practice recommendations. However, existing evidences, though limited, are still suggesting unmet needs during the palliative phase of the disease. Current literature focuses on the assessment and management of potential issues related to genital cancers - primarily gynecological, breast, and prostate cancers - but also on post-cancer experiences. The sexual health needs of patients in palliative care are understudied, except one study that reports how patients are considering sexuality as an important aspect of their lives, even during the last weeks to days of life. In the aim of developing an efficient complex intervention for the population of patients with cancer in palliative situations, it is necessary to identify the needs, facilitators, and modalities required for promoting sexual health in this population (beyond the extensively studied cases of genital cancers). A solely patient-centred approach would be limiting, and this objective requires an approach dedicated to the life partners as well. To assess satisfaction related to sexual health and gain insights regarding the expectations of patients and their partners towards the healthcare system, the study INTIMI-K will utilize a mixed methodology involving the use of a questionnaire, including validated scales, and semi-structured interviews. Patients aged 18 and older, diagnosed with advanced solid or hematological cancers, along with their life partner will be included.
Eligibility Criteria
Inclusion Criteria: For patients: * Individuals aged 18 and older, * Patients diagnosed with advanced solid or hematological cancers, * Whether or not undergoing specific treatment for the ongoing oncological condition, * Having a cancer diagnosis for more than 3 months (baseline diagnosis consultation), * Capable of understanding study-related documents, * Capable of completing questionnaires, * Fluent in French, * Individuals who have not objected to participating in the study. For partners: * Individuals aged 18 and older, * Individuals whose life partner has been diagnosed with advanced solid or hematological cancer for more than 3 months, whether or not they have received treatment, * Capable of understanding study-related documents, * Capable of completing questionnaires, * Fluent in French, * Individuals who have not objected to participating in the study. Exclusion Criteria: * Individuals unable to complete the entire questionnaire due to their clinical condition. * Individuals under guardians, curators, or legal protection.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06229158 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Advanced Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06229158 currently recruiting?
Yes, NCT06229158 is actively recruiting participants. Contact the research team at roxane.donz@chu-lyon.fr for enrollment information.
Where is the NCT06229158 trial being conducted?
This trial is being conducted at Lyon, France, Lyon, France, Lyon, France.
Who is sponsoring the NCT06229158 clinical trial?
NCT06229158 is sponsored by Hospices Civils de Lyon. The trial plans to enroll 120 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.